IT1274015B - Uso del ceruletide (takus) nel trattamento della psoriasi - Google Patents

Uso del ceruletide (takus) nel trattamento della psoriasi

Info

Publication number
IT1274015B
IT1274015B ITMI940298A ITMI940298A IT1274015B IT 1274015 B IT1274015 B IT 1274015B IT MI940298 A ITMI940298 A IT MI940298A IT MI940298 A ITMI940298 A IT MI940298A IT 1274015 B IT1274015 B IT 1274015B
Authority
IT
Italy
Prior art keywords
ceruletide
psoriasis
treatment
takus
Prior art date
Application number
ITMI940298A
Other languages
English (en)
Italian (it)
Inventor
Keokharovna Kelesheva Lamara
Original Assignee
Theokhar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theokhar filed Critical Theokhar
Publication of ITMI940298A0 publication Critical patent/ITMI940298A0/it
Priority to ITMI940298A priority Critical patent/IT1274015B/it
Priority to IL11257895A priority patent/IL112578A0/xx
Priority to PL95311159A priority patent/PL311159A1/xx
Priority to HU9503295A priority patent/HU9503295D0/hu
Priority to ZA951137A priority patent/ZA951137B/xx
Priority to CA002160251A priority patent/CA2160251A1/en
Priority to EP95914489A priority patent/EP0696203A1/en
Priority to MX9504335A priority patent/MX9504335A/es
Priority to AU21465/95A priority patent/AU2146595A/en
Priority to PCT/IB1995/000282 priority patent/WO1995022346A1/en
Priority to FI954912A priority patent/FI954912A0/fi
Priority to JP7521701A priority patent/JPH08509245A/ja
Publication of ITMI940298A1 publication Critical patent/ITMI940298A1/it
Priority to NO954115A priority patent/NO954115L/no
Application granted granted Critical
Publication of IT1274015B publication Critical patent/IT1274015B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ITMI940298A 1994-02-18 1994-02-18 Uso del ceruletide (takus) nel trattamento della psoriasi IT1274015B (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
ITMI940298A IT1274015B (it) 1994-02-18 1994-02-18 Uso del ceruletide (takus) nel trattamento della psoriasi
IL11257895A IL112578A0 (en) 1994-02-18 1995-02-08 Pharmaceutical compositions comprising ceruletide diethyl amine salt for the treatment of psoriasis
EP95914489A EP0696203A1 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
PCT/IB1995/000282 WO1995022346A1 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
ZA951137A ZA951137B (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
CA002160251A CA2160251A1 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
PL95311159A PL311159A1 (en) 1994-02-18 1995-02-13 Pharmaceutical composition for treating psoriasis
MX9504335A MX9504335A (es) 1994-02-18 1995-02-13 Uso de la sal de amina dietilica de ceruletida en el tratamiento de la psoriasis.
AU21465/95A AU2146595A (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
HU9503295A HU9503295D0 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
FI954912A FI954912A0 (fi) 1994-02-18 1995-02-13 Keruletidin dietyyliamiinisuolan käyttö psoriaasin hoidossa
JP7521701A JPH08509245A (ja) 1994-02-18 1995-02-13 乾癬の治療におけるセルレチドジエチルアミン塩の使用
NO954115A NO954115L (no) 1994-02-18 1995-10-16 Anvendelse av ceruletid-dietylaminsalt ved behandling av psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940298A IT1274015B (it) 1994-02-18 1994-02-18 Uso del ceruletide (takus) nel trattamento della psoriasi

Publications (3)

Publication Number Publication Date
ITMI940298A0 ITMI940298A0 (it) 1994-02-18
ITMI940298A1 ITMI940298A1 (it) 1995-08-19
IT1274015B true IT1274015B (it) 1997-07-14

Family

ID=11367909

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI940298A IT1274015B (it) 1994-02-18 1994-02-18 Uso del ceruletide (takus) nel trattamento della psoriasi

Country Status (13)

Country Link
EP (1) EP0696203A1 (no)
JP (1) JPH08509245A (no)
AU (1) AU2146595A (no)
CA (1) CA2160251A1 (no)
FI (1) FI954912A0 (no)
HU (1) HU9503295D0 (no)
IL (1) IL112578A0 (no)
IT (1) IT1274015B (no)
MX (1) MX9504335A (no)
NO (1) NO954115L (no)
PL (1) PL311159A1 (no)
WO (1) WO1995022346A1 (no)
ZA (1) ZA951137B (no)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034531C2 (de) * 1980-09-12 1986-09-18 Farmitalia Carlo Erba S.p.A., Mailand/Milano Verwendung von Polypeptiden als Analgetikum in der Human- und Tiermedizin
JPS6041052B2 (ja) * 1981-04-07 1985-09-13 塩野義製薬株式会社 向精神薬

Also Published As

Publication number Publication date
AU2146595A (en) 1995-09-04
ITMI940298A1 (it) 1995-08-19
WO1995022346A1 (en) 1995-08-24
NO954115D0 (no) 1995-10-16
CA2160251A1 (en) 1995-08-24
FI954912A7 (fi) 1995-10-16
PL311159A1 (en) 1996-02-05
ZA951137B (en) 1995-12-01
HU9503295D0 (en) 1996-01-29
IL112578A0 (en) 1995-05-26
FI954912L (fi) 1995-10-16
JPH08509245A (ja) 1996-10-01
MX9504335A (es) 1997-05-31
EP0696203A1 (en) 1996-02-14
ITMI940298A0 (it) 1994-02-18
NO954115L (no) 1995-10-16
FI954912A0 (fi) 1995-10-16

Similar Documents

Publication Publication Date Title
ES2139574T3 (es) Nuevos gases propulsores y su uso en preparaciones medicas.
TR199701212T1 (xx) �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�.
ATE32730T1 (de) Indikatormarkierte konjugate von metallothionein und zielsuchenden, biologisch aktiven molekuelen.
ITBO910163A0 (it) Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
ES2125358T3 (es) Agentes para la clarificacion del agua con polivinilaminas cuaternizadas.
DE58908544D1 (de) Benzamid gegen kognitive Erkrankungen.
ITMI932412A1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
ATE88343T1 (de) Anxiolytisches praeparat.
ITMI912509A0 (it) Uso della nimesulide nel trattamento della cataratta
FI852730A0 (fi) (pyrrol-1-yl) -fenyl-dihydropyridazinoner, deras framstaellning och anvaendning.
FI830523A0 (fi) Anti-inflammatoriska och/eller smaerta lindrande 2,3-diaryl-5-halotiofener
IT1252603B (it) 2,4-diamino-6 piperidino pirimidina-3 ossido topico sul glande nel trattamento delle impotenze erettili
IT8420213A0 (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi.
IT1274015B (it) Uso del ceruletide (takus) nel trattamento della psoriasi
GB8327598D0 (en) Pharmacologically active diarylindane-13-diones
ITMI912466A1 (it) Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche
BR9704964A (pt) Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais
ES2160969T3 (es) Derivados anticonvulsivos utiles en el tratamiento de la psoriasis.
ITMI941064A0 (it) Uso della s-benzoilossimetiltiamina nel trattamento del diabete
ITRM950686A1 (it) Hcg nel sarcoma di kaposi
ITFI930069A1 (it) Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare.
ES2141923T3 (es) Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.
ES2173158T3 (es) Reduccion del tejido adiposo utilizando colagenasa
IT1302920B1 (it) Uso della propoli nel trattamento della vitiligine e della psoriasi.

Legal Events

Date Code Title Description
0001 Granted